002880.SZ · 卫光生物
China A-shares · RS rating 35 · As of 2026-10-14
| Price | 21.06 CNY |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 35 / 34 / 55 / 39 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 8 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +2.4% |
| Distance from 52-week high | +32.1% |
| Market cap (USD) | $760.1M |